Noriko Kudo, Hidenaga Yamamori, Tamaki Ishima, Kiyotaka Nemoto, Yuka Yasuda, Michiko Fujimoto, . . . Ryota Hashimoto. (2020). Plasma levels of matrix metalloproteinase‐9 (MMP‐9) are associated with cognitive performance in patients with schizophrenia. Wiley.
Chicago Style (17th ed.) CitationNoriko Kudo, et al. Plasma Levels of Matrix Metalloproteinase‐9 (MMP‐9) Are Associated with Cognitive Performance in Patients with Schizophrenia. Wiley, 2020.
MLA (9th ed.) CitationNoriko Kudo, et al. Plasma Levels of Matrix Metalloproteinase‐9 (MMP‐9) Are Associated with Cognitive Performance in Patients with Schizophrenia. Wiley, 2020.
Warning: These citations may not always be 100% accurate.